Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 23590855)

1.

Direct healthcare costs of glaucoma treatment.

Rahman MQ, Beard SM, Discombe R, Sharma R, Montgomery DM.

Br J Ophthalmol. 2013 Jun;97(6):720-4. doi: 10.1136/bjophthalmol-2012-302525. Epub 2013 Apr 16.

PMID:
23590855
2.

Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe.

Traverso CE, Walt JG, Kelly SP, Hommer AH, Bron AM, Denis P, Nordmann JP, Renard JP, Bayer A, Grehn F, Pfeiffer N, Cedrone C, Gandolfi S, Orzalesi N, Nucci C, Rossetti L, Azuara-Blanco A, Bagnis A, Hitchings R, Salmon JF, Bricola G, Buchholz PM, Kotak SV, Katz LM, Siegartel LR, Doyle JJ.

Br J Ophthalmol. 2005 Oct;89(10):1245-9.

3.

Surveillance of glaucoma medical therapy in a Glasgow teaching hospital: 26 years' experience.

Rahman MQ, Montgomery DM, Lazaridou MN.

Br J Ophthalmol. 2009 Dec;93(12):1572-5. doi: 10.1136/bjo.2008.151522. Epub 2009 Jul 23.

PMID:
19628493
4.

Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.

Pelletier EM, Ogale S, Yu E, Brunetta P, Garg J.

Clin Ther. 2009 Nov;31(11):2653-64. doi: 10.1016/j.clinthera.2009.11.032.

PMID:
20110008
5.

Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US.

Pike C, Birnbaum HG, Schiller M, Sharma H, Burge R, Edgell ET.

Pharmacoeconomics. 2010;28(5):395-409. doi: 10.2165/11531040-000000000-00000.

PMID:
20402541
6.

A review of glaucoma treatment in Scotland 1994-2004.

Macleod SM, Clark R, Forrest J, Bain M, Bateman N, Azuara-Blanco A.

Eye (Lond). 2008 Feb;22(2):251-5. Epub 2006 Sep 22.

PMID:
17001326
7.

Hyperemia-associated costs of medication changes in glaucoma patients treated initially with prostaglandin analogs.

Schwartz GF, Tan J, Kotak S.

J Ocul Pharmacol Ther. 2009 Dec;25(6):555-61. doi: 10.1089/jop.2009.0057.

PMID:
20028264
9.

The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health care.

Bateman DN, Clark R, Azuara-Blanco A, Bain M, Forrest J.

Br J Ophthalmol. 2002 May;86(5):551-4.

10.

Assessment of the cost effectiveness of travoprost versus latanoprost as single agents for treatment of glaucoma in France.

Payet S, Denis P, Berdeaux G, Launois R.

Clin Drug Investig. 2008;28(3):183-98.

PMID:
18266403
11.

Glaucoma costs in Denmark in treatment naive patients.

Olsen J, Berdeaux G, Skov J.

Acta Ophthalmol. 2013 Feb;91(1):25-31. doi: 10.1111/j.1755-3768.2011.02212.x. Epub 2011 Aug 11.

PMID:
21834919
12.

Healthcare utilization and costs of patients with rosacea in an insured population.

Romanowicz M, Stephenson JJ, Del Rosso JQ, Lenhart G.

J Drugs Dermatol. 2008 Jan;7(1):41-9.

PMID:
18246697
13.
14.

The costs of childhood epilepsy in Italy: comparative findings from three health care settings.

Guerrini R, Battini R, Ferrari AR, Veggiotti P, Besana D, Gobbi G, Pezzani M, Berta E, Tetto A, Beghi E, Monticelli ML, Tediosi F, Garattini L, Russo S, Rasmini P, Amadi A, Quarti P, Fabrizzi R; Epilepsy Collaborative Study Group.

Epilepsia. 2001 May;42(5):641-6.

PMID:
11380572
15.

Association between medication supplies and healthcare costs in older adults from an urban healthcare system.

Stroupe KT, Murray MD, Stump TE, Callahan CM.

J Am Geriatr Soc. 2000 Jul;48(7):760-8.

PMID:
10894314
16.

A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden.

Lindblom B, Nordmann JP, Sellem E, Chen E, Gold R, Polland W, Williamson W, Buchholz P, Walt JG, Groleau D, Curry A, Evans SJ.

Acta Ophthalmol Scand. 2006 Feb;84(1):74-83.

PMID:
16445443
17.

Persistence of glaucoma medical therapy in the Glasgow Glaucoma Database.

Rahman MQ, Abeysinghe SS, Kelly S, Roskell NS, Shannon PR, Abdlseaed AA, Montgomery DM.

Br J Ophthalmol. 2011 Jul;95(7):966-70. doi: 10.1136/bjo.2010.188607. Epub 2011 Jan 21.

PMID:
21258080
18.

Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources.

Ruof J, Hülsemann JL, Mittendorf T, Handelmann S, von der Schulenburg JM, Zeidler H, Merkesdal S.

Ann Rheum Dis. 2003 Jun;62(6):544-9.

19.

Cost of health care for a community of older adults in an urban academic healthcare system.

Callahan CM, Stump TE, Stroupe KT, Tierney WM.

J Am Geriatr Soc. 1998 Nov;46(11):1371-7.

PMID:
9809758
20.

Healthcare costs and obesity prevention: drug costs and other sector-specific consequences.

Rappange DR, Brouwer WB, Hoogenveen RT, Van Baal PH.

Pharmacoeconomics. 2009;27(12):1031-44. doi: 10.2165/11319900-000000000-00000.

PMID:
19908927
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk